Correction to: Radiopharmaceutical tracers for cardiac imaging

Osamu Manabe¹, Tatsuya Kikuchi², Arthur J H A Scholte³, Mohammed El Mahdiui³, Ryuichi Nishii⁴, Ming-Rong Zhang², Eriko Suzuki¹, Keiichiro Yoshinaga⁵

Affiliations

¹ Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
² Department of Radiopharmaceutical Development, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Chiba, Japan.
³ Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Diagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
⁵ Diagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. yoshinaga.keiichiro@qst.go.jp.

PMID: 29368086
PMCID: PMC6828419
DOI: 10.1007/s12350-018-1184-0

Published Erratum

Correction to: Radiopharmaceutical tracers for cardiac imaging

Osamu Manabe et al. J Nucl Cardiol. 2018 Aug.

. 2018 Aug;25(4):1237-1241.

doi: 10.1007/s12350-018-1184-0.

Authors

Osamu Manabe¹, Tatsuya Kikuchi², Arthur J H A Scholte³, Mohammed El Mahdiui³, Ryuichi Nishii⁴, Ming-Rong Zhang², Eriko Suzuki¹, Keiichiro Yoshinaga⁵

Affiliations

¹ Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
² Department of Radiopharmaceutical Development, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Chiba, Japan.
³ Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Diagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
⁵ Diagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. yoshinaga.keiichiro@qst.go.jp.

PMID: 29368086
PMCID: PMC6828419
DOI: 10.1007/s12350-018-1184-0

Abstract

Regrettably the original version of the above article contained errors in the three chemical structures presented in the 'Atherosclerosis imaging' section of Table 5, namely: ^99mTc annexin V, ⁶⁸Ga DOTATATE, and ⁶⁴Cu DOTATATE; the chemical structures have been corrected in Table presented here. In addition, the radiopharmaceutical for isotope ⁶⁷Ga has been corrected to ⁶⁷Ga citrate, and many of the radiopharmaceuticals presented at the end of the table have been corrected.

PubMed Disclaimer

Erratum for

Radiopharmaceutical tracers for cardiac imaging.
Manabe O, Kikuchi T, Scholte AJHA, El Mahdiui M, Nishii R, Zhang MR, Suzuki E, Yoshinaga K. Manabe O, et al. J Nucl Cardiol. 2018 Aug;25(4):1204-1236. doi: 10.1007/s12350-017-1131-5. Epub 2017 Dec 1. J Nucl Cardiol. 2018. PMID: 29196910 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Radiopharmaceutical tracers for cardiac imaging

Affiliations

Correction to: Radiopharmaceutical tracers for cardiac imaging

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources